Neogenomics (NEO) Other Operating Expenses (2010 - 2026)

Neogenomics (NEO) has reported Other Operating Expenses for 17 consecutive years, with $23.8 million the latest figure, recorded in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $23.8 million, up 5.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $120.9 million (up 32.32% YoY), and the FY2025 annual result was $119.8 million, up 41.47% from the prior year.
• Other Operating Expenses was $23.8 million for Q1 2026 at Neogenomics, down from $24.1 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $44.1 million in Q2 2025 and troughed at $16.3 million in Q1 2023.
• Average Other Operating Expenses over 5 years is $21.8 million, with a median of $20.2 million recorded in 2024.
• Year-over-year, Other Operating Expenses dropped 0.89% in 2022 and jumped 89.98% in 2025.
• Over 5 years, Other Operating Expenses stood at $17.1 million in 2022, then climbed by 5.43% to $18.1 million in 2023, then jumped by 33.06% to $24.0 million in 2024, then climbed by 0.1% to $24.1 million in 2025, then slipped by 0.99% to $23.8 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $23.8 million in Q1 2026, $24.1 million in Q4 2025, and $28.9 million in Q3 2025.